Anti-Human Bispecific antibodies

Anti-Human Bispecific antibodies

Catalog Product Name Structure M.W. Purity Pricing
Therapeutic antibody
BP-50614Blinatumomab Biosimilar – Anti-CD19/CD3E Bispecific AntibodyMolecular structure of the compound: Blinatumomab Biosimilar – Anti-CD19/CD3E Bispecific Antibody54.1kDaPricing
BP-50615Amivantamab Biosimilar – Anti-EGFR/MET Bispecific AntibodyMolecular structure of the compound: Amivantamab Biosimilar – Anti-EGFR/MET Bispecific Antibody145.88 kDaPricing
BP-50616Mosunetuzumab Biosimilar – Anti-CD20/CD3 Bispecific AntibodyMolecular structure of the compound: Mosunetuzumab Biosimilar – Anti-CD20/CD3 Bispecific Antibody144 kDaPricing
BP-50617Tebentafusp Biosimilar – Anti-gp100/CD3 Bispecific AntibodyMolecular structure of the compound: Tebentafusp Biosimilar – Anti-gp100/CD3 Bispecific Antibody76.16 kDaPricing
BP-50618Teclistamab Biosimilar – Anti-BCMA/CD3 Bispecific AntibodyMolecular structure of the compound: Teclistamab Biosimilar – Anti-BCMA/CD3 Bispecific Antibody143.64 kDaPricing
BP-50619Elranatamab Biosimilar – Anti-BCMA/CD3 Bispecific AntibodyMolecular structure of the compound: Elranatamab Biosimilar – Anti-BCMA/CD3 Bispecific Antibody145.441 kDaPricing
BP-50620Epcoritamab Biosimilar – Anti-CD20/CD3 Bispecific AntibodyMolecular structure of the compound: Epcoritamab Biosimilar – Anti-CD20/CD3 Bispecific Antibody146.28 kDaPricing
BP-50621Glofitamab Biosimilar – Anti-CD20/CD3 Bispecific AntibodyMolecular structure of the compound: Glofitamab Biosimilar – Anti-CD20/CD3 Bispecific Antibody194 kDaPricing
BP-50622Talquetamab Biosimilar – Anti-GPRC5D/CD3 Bispecific AntibodyMolecular structure of the compound: Talquetamab Biosimilar – Anti-GPRC5D/CD3 Bispecific Antibody144.58 kDaPricing
BP-50623Tarlatamab Biosimilar – Anti-GPRC5D/CD3 Bispecific AntibodyMolecular structure of the compound: Tarlatamab Biosimilar – Anti-GPRC5D/CD3 Bispecific Antibody105.07 kDaPricing
BP-50624Zanidatamab Biosimilar – Anti-HER2 (ECD2 and ECD4) Bispecific AntibodyMolecular structure of the compound: Zanidatamab Biosimilar – Anti-HER2 (ECD2 and ECD4) Bispecific Antibody124.65kDaPricing
BP-50625Zenocutuzumab Biosimilar – Anti-HER2/HER3 Bispecific AntibodyMolecular structure of the compound: Zenocutuzumab Biosimilar – Anti-HER2/HER3 Bispecific Antibody145.76 kDaPricing
BP-50626Linvoseltamab Biosimilar – Anti-BCMA/CD3 Bispecific AntibodyMolecular structure of the compound: Linvoseltamab Biosimilar – Anti-BCMA/CD3 Bispecific Antibody145.51 kDaPricing
BP-50627Anti-Human CD3 / CD3 Bispecific AntibodiesMolecular structure of the compound: Anti-Human CD3 / CD3 Bispecific AntibodiesPricing
BP-50628Anti-Human CD3 / CD3 Bispecific AntibodiesMolecular structure of the compound: Anti-Human CD3 / CD3 Bispecific AntibodiesPricing
BP-50629Anti-Human CD3 / CD3 Bispecific AntibodiesMolecular structure of the compound: Anti-Human CD3 / CD3 Bispecific AntibodiesPricing
BP-50630Cibisatamab – Anti-CEA/CD3 Bispecific AntibodyMolecular structure of the compound: Cibisatamab – Anti-CEA/CD3 Bispecific Antibody171 kDaPricing
BP-50631Fepixnebart– Anti-TGFα/epiregulin Bispecific AntibodyMolecular structure of the compound: Fepixnebart– Anti-TGFα/epiregulin Bispecific Antibody145.44 kDaPricing
BP-50632Ivonescimab– Anti-PD-1/VEGF Bispecific AntibodyMolecular structure of the compound: Ivonescimab– Anti-PD-1/VEGF Bispecific Antibody201.1 kDaPricing
BP-50633Solitomab– AntiEpCAM/CD3 Bispecific AntibodyMolecular structure of the compound: Solitomab– AntiEpCAM/CD3 Bispecific Antibody53.94 kDaPricing
BP-50634Cadonilimab– Anti-PD-1/CTLA4 Bispecific AntibodyMolecular structure of the compound: Cadonilimab– Anti-PD-1/CTLA4 Bispecific Antibody198.64 kDaPricing
BP-50635Obrindatamab– Anti-B7-H3/CD3 Bispecific AntibodyMolecular structure of the compound: Obrindatamab– Anti-B7-H3/CD3 Bispecific Antibody109.06 kDaPricing
BP-50636Gresonitamab -Anti CLDN18.2/CD3 Bispecific AntibodyMolecular structure of the compound: Gresonitamab -Anti CLDN18.2/CD3 Bispecific Antibody106 kDaPricing
BP-50637Anbenitamab – Anti-HER2 Bispecific AntibodyMolecular structure of the compound: Anbenitamab – Anti-HER2 Bispecific Antibody145.16 kDaPricing
BP-50638Xentuzumab- Anti-Human IGF1 and IGF2 Bispecific AntibodyMolecular structure of the compound: Xentuzumab- Anti-Human IGF1 and IGF2 Bispecific Antibody143.7 kDaPricing
BP-50639Rovelizumab- Anti-Human CD11/CD18 Bispecific AntibodyMolecular structure of the compound: Rovelizumab- Anti-Human CD11/CD18 Bispecific Antibody145.98 kDaPricing
BP-50640Pasotuxizumab- Anti-Human CD3/PSMA Bispecific AntibodyMolecular structure of the compound: Pasotuxizumab- Anti-Human CD3/PSMA Bispecific Antibody53.55 kDaPricing
BP-50641Pavurutamab- Anti-Human CD3/BCMA Bispecific AntibodyMolecular structure of the compound: Pavurutamab- Anti-Human CD3/BCMA Bispecific Antibody105.78 kDaPricing
BP-50642Trontinemab- Anti-Human Aβ/TFR1 Bispecific AntibodyMolecular structure of the compound: Trontinemab- Anti-Human Aβ/TFR1 Bispecific Antibody194.25 kDaPricing
BP-50643Surovatamig- Anti-Human CD19/CD3 Bispecific AntibodyMolecular structure of the compound: Surovatamig- Anti-Human CD19/CD3 Bispecific Antibody110.46 kDaPricing
BP-50644Ubamatamab-Anti-human Mucin 16 (MUC16)/CD3 Bispecific AntibodyMolecular structure of the compound: Ubamatamab-Anti-human Mucin 16 (MUC16)/CD3 Bispecific Antibody146.081 kDaPricing
BP-50645Izalontamab - anti-human EGFR/HER3 Bispecific AntibodyMolecular structure of the compound: Izalontamab - anti-human EGFR/HER3 Bispecific Antibody197.18 kDaPricing
BP-50646Bafisontamab - anti-human EGFR and cMET Bispecific AntibodyMolecular structure of the compound: Bafisontamab - anti-human EGFR and cMET Bispecific Antibody237.63 kDaPricing
BP-50647Vibecotamab - anti-human CD123 and CD3 Bispecific AntibodyMolecular structure of the compound: Vibecotamab - anti-human CD123 and CD3 Bispecific Antibody126.15 kDaPricing
BP-50648Runimotamab - anti-human HER2 and CD3 Bispecific AntibodyMolecular structure of the compound: Runimotamab - anti-human HER2 and CD3 Bispecific Antibody146.081 kDaPricing
BP-50649Vanucizumab - anti-human VEGF-A/Ang-2 Bispecific AntibodyMolecular structure of the compound: Vanucizumab - anti-human VEGF-A/Ang-2 Bispecific Antibody146.89 kDaPricing
BP-50650Voxalatamab - Anti-Human CD3/PSMA Bispecific AntibodyMolecular structure of the compound: Voxalatamab - Anti-Human CD3/PSMA Bispecific Antibody144.68 kDaPricing
BP-50651Odronextamab - Anti-Human CD3/CD20 Bispecific AntibodyMolecular structure of the compound: Odronextamab - Anti-Human CD3/CD20 Bispecific Antibody144 kDaPricing
BP-50652Sonelokimab - Anti-Human IL-17F and IL-17A/F Bispecific AntibodyMolecular structure of the compound: Sonelokimab - Anti-Human IL-17F and IL-17A/F Bispecific Antibody40.11 kDaPricing
BP-50653Fazpilodemab - Anti-Human FGFR1c and Klothoβ Bispecific AntibodyMolecular structure of the compound: Fazpilodemab - Anti-Human FGFR1c and Klothoβ Bispecific Antibody144.48 kDaPricing
BP-50654Vudalimab - Anti-Human PD-1 and CTLA-4 Bispecific AntibodyMolecular structure of the compound: Vudalimab - Anti-Human PD-1 and CTLA-4 Bispecific Antibody144.5 kDaPricing
BP-50655Vobarilizumab - Anti-Human IL-6R and ALB Bispecific AntibodyMolecular structure of the compound: Vobarilizumab - Anti-Human IL-6R and ALB Bispecific Antibody25.69 kDaPricing
BP-50656Acasunlimab - Anti-Human PD-L1 and 4-1BB Bispecific AntibodyMolecular structure of the compound: Acasunlimab - Anti-Human PD-L1 and 4-1BB Bispecific Antibody143.86 kDaPricing
BP-50657Flotetuzumab - Anti-Human CD123/CD3 Bispecific AntibodyMolecular structure of the compound: Flotetuzumab - Anti-Human CD123/CD3 Bispecific Antibody58.77 kDaPricing
BP-50658Linclatamig - Anti-Human LY6G6D and CD3 Bispecific AntibodyMolecular structure of the compound: Linclatamig - Anti-Human LY6G6D and CD3 Bispecific Antibody145.72 kDaPricing
BP-50659Fidasimtamab - Anti-Human HER2/PD-1 Bispecific AntibodyMolecular structure of the compound: Fidasimtamab - Anti-Human HER2/PD-1 Bispecific Antibody144.62 kDaPricing
BP-50660Alnuctamab- Anti-Human BCMA and CD3 Bispecific AntibodyMolecular structure of the compound: Alnuctamab- Anti-Human BCMA and CD3 Bispecific Antibody192.13 kDaPricing
BP-50661Tecaginlimab- Anti-Human CD40 and 4-1BB Bispecific AntibodyMolecular structure of the compound: Tecaginlimab- Anti-Human CD40 and 4-1BB Bispecific Antibody145.098 kDaPricing
BP-50662Denecimig- Anti-Human Factor X and Factor Ixa Bispecific AntibodyMolecular structure of the compound: Denecimig- Anti-Human Factor X and Factor Ixa Bispecific Antibody145.46 kDaPricing
BP-50663Anti-DLL3/CD3 Bispecific AntibodyMolecular structure of the compound: Anti-DLL3/CD3 Bispecific Antibody145.18 kDaPricing